Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment

Sickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative approach. Nevertheless the decision to perform a marrow transplant includes the risk o...

Full description

Saved in:
Bibliographic Details
Main Authors: Katia Paciaroni, Gioia De Angelis, Cristiano Gallucci, Cecilia Alfieri, Michela Ribersani, Andrea Roveda, Antonella Isgrò, Marco Marziali, Ivan Pietro Aloi, Alessandro Inserra, Javid Gaziev, Pietro Sodani, Guido Lucarelli
Format: Article
Language:English
Published: PAGEPress Publications 2015-08-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/2060
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846143839219220480
author Katia Paciaroni
Gioia De Angelis
Cristiano Gallucci
Cecilia Alfieri
Michela Ribersani
Andrea Roveda
Antonella Isgrò
Marco Marziali
Ivan Pietro Aloi
Alessandro Inserra
Javid Gaziev
Pietro Sodani
Guido Lucarelli
author_facet Katia Paciaroni
Gioia De Angelis
Cristiano Gallucci
Cecilia Alfieri
Michela Ribersani
Andrea Roveda
Antonella Isgrò
Marco Marziali
Ivan Pietro Aloi
Alessandro Inserra
Javid Gaziev
Pietro Sodani
Guido Lucarelli
author_sort Katia Paciaroni
collection DOAJ
description Sickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative approach. Nevertheless the decision to perform a marrow transplant includes the risk of major complications  and mortality transplant related. The infections represent the main cause of mortality for SCA patients undergoing transplant. Invasive Pulmonary Aspergillosis (IPA) is a devastating opportunistic infection and remains a significant cause of morbidity and mortality in HSCT recipients. Data regarding IPA in the setting of SCA are lacking. In the present report,  we describe a patient with SCA who developed IPA after allogeneic bone marrow transplant. The fungal infection was treated by systemic antifungal therapy in addition to the surgery, despite  mild chronic GVHD and with continuing immunosuppression therapy. This case shows that IPA occurring in bone marrow recipient with SCA can be successful treated
format Article
id doaj-art-0a726cdebb4d4721b7ae2ce4b32b0f63
institution Kabale University
issn 2035-3006
language English
publishDate 2015-08-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-0a726cdebb4d4721b7ae2ce4b32b0f632024-12-02T09:47:38ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062015-08-0171e2015006e201500610.4084/mjhid.2015.0061516Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful TreatmentKatia Paciaroni0Gioia De Angelis1Cristiano Gallucci2Cecilia AlfieriMichela Ribersani3Andrea Roveda4Antonella Isgrò5Marco Marziali6Ivan Pietro Aloi7Alessandro Inserra8Javid Gaziev9Pietro Sodani10Guido Lucarelli11International Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyDepartments of Surgery, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, ItalyDepartments of Surgery, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalyInternational Centre for Transplantation in Thalassemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Policlinic of “Tor Vergata” University, Rome, ItalySickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative approach. Nevertheless the decision to perform a marrow transplant includes the risk of major complications  and mortality transplant related. The infections represent the main cause of mortality for SCA patients undergoing transplant. Invasive Pulmonary Aspergillosis (IPA) is a devastating opportunistic infection and remains a significant cause of morbidity and mortality in HSCT recipients. Data regarding IPA in the setting of SCA are lacking. In the present report,  we describe a patient with SCA who developed IPA after allogeneic bone marrow transplant. The fungal infection was treated by systemic antifungal therapy in addition to the surgery, despite  mild chronic GVHD and with continuing immunosuppression therapy. This case shows that IPA occurring in bone marrow recipient with SCA can be successful treatedhttp://www.mjhid.org/index.php/mjhid/article/view/2060Sickle Cell Anaemia- Aspergillus Infection-Bone Marrow Transplant
spellingShingle Katia Paciaroni
Gioia De Angelis
Cristiano Gallucci
Cecilia Alfieri
Michela Ribersani
Andrea Roveda
Antonella Isgrò
Marco Marziali
Ivan Pietro Aloi
Alessandro Inserra
Javid Gaziev
Pietro Sodani
Guido Lucarelli
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
Mediterranean Journal of Hematology and Infectious Diseases
Sickle Cell Anaemia- Aspergillus Infection-Bone Marrow Transplant
title Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
title_full Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
title_fullStr Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
title_full_unstemmed Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
title_short Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
title_sort invasive pulmonary aspergillosis in a sickle cell patient transplant recipient a successful treatment
topic Sickle Cell Anaemia- Aspergillus Infection-Bone Marrow Transplant
url http://www.mjhid.org/index.php/mjhid/article/view/2060
work_keys_str_mv AT katiapaciaroni invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT gioiadeangelis invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT cristianogallucci invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT ceciliaalfieri invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT michelaribersani invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT andrearoveda invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT antonellaisgro invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT marcomarziali invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT ivanpietroaloi invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT alessandroinserra invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT javidgaziev invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT pietrosodani invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment
AT guidolucarelli invasivepulmonaryaspergillosisinasicklecellpatienttransplantrecipientasuccessfultreatment